INO
Inovio Pharmaceuticals Inc
1.20$
-3.2%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 14.5% | 14.5% | 28.7% | 43.2% | 2,904.7% | 7,612.2% | 1,037.2% | 3.8% | 6.5% | 402.7% | 706.8% | 220.6% | 377.3% | 306.1% | 649.2% | 244.2% | 462.4% | 142.4% | 250.8% | 233.5% | 312.5% | 2,140.5% | 1,271.7% | 266.6% | 53.6% | 421.1% | 1,437.4% | 4,574.1% | |
| 85.5% | 85.5% | 71.3% | 56.8% | 100.0% | 100.0% | 100.0% | 96.2% | 93.5% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | -1,337.4% | 100.0% | |
| 97.6% | 97.6% | 137.4% | 10.3% | 1,301.2% | 2,666.0% | 561.1% | 209.5% | 245.4% | 200.2% | 274.1% | 103.2% | 215.7% | 204.5% | 436.7% | 158.7% | 326.1% | 142.4% | 250.8% | 233.5% | 312.5% | 2,140.5% | 1,271.7% | 14,043.6% | 1,828.5% | 10,417.7% | 34,727.1% | 82,957.4% | |
| – | 67.6% | 110.5% | 126.0% | 1,930.3% | 5,671.1% | 525.2% | 109.4% | 233.0% | 230.5% | 477.0% | 149.9% | 197.1% | 122.4% | 261.7% | 101.3% | 151.7% | 44.5% | 67.6% | 67.0% | 96.2% | 661.6% | 502.6% | 3,028.7% | 878.8% | 5,718.9% | 16,989,813.4% | 50,013.9% | |
| 168.7% | 168.7% | 259.1% | 159.1% | 3,231.5% | 8,337.1% | 1,086.3% | 322.7% | 484.8% | 430.7% | 751.1% | 253.0% | 412.8% | 326.9% | 698.4% | 260.0% | 477.7% | 187.0% | 318.4% | 300.5% | 408.7% | 2,802.1% | 1,774.2% | 17,072.3% | 2,707.4% | 17,400.3% | 51,014.3% | 132,971.3% | |
| -83.1% | -83.1% | -187.8% | -125.2% | -3,131.5% | -8,237.1% | -986.3% | -283.6% | -384.8% | -330.7% | -651.1% | -153.0% | -312.8% | -220.9% | -570.4% | -145.1% | -377.7% | -84.5% | -215.5% | -198.1% | -308.7% | -2,702.1% | -1,674.2% | -16,972.3% | -2,607.4% | -17,300.3% | -51,616.9% | -132,871.3% | |
| 0.3% | 0.3% | 0.5% | 0.5% | 2.9% | 25.4% | 0.0% | 60.9% | 0.0% | 71.2% | 2.3% | 115.2% | 24.5% | 0.4% | 119.7% | 654.7% | 32.1% | 12.8% | 0.4% | 0.1% | 1.1% | 193.3% | 117.4% | 109.1% | 12.2% | 147.0% | 81.7% | 0.0% | |
| -79.5% | -79.5% | -199.5% | -199.1% | -3,117.4% | 0.0% | 0.0% | -283.6% | -417.6% | -259.5% | -648.8% | -268.2% | -288.3% | -132.2% | -478.6% | -490.7% | -345.6% | -76.9% | -208.5% | -208.9% | -311.0% | -2,938.0% | -2,259.7% | -17,109.9% | -2,726.7% | -16,239.9% | -49,254.3% | -130,000.0% | |
| -7.2% | -7.2% | 12.6% | 14.3% | 30.0% | -2,469.7% | -46.1% | 118.0% | -25.0% | -168.8% | -35.4% | 128.4% | -66.5% | -166.2% | -196.9% | 654.3% | -35.6% | -5.2% | -13.1% | 4.2% | 7.1% | -6.3% | 704.3% | 24.5% | 21.1% | 0.0% | -49,205,014.7% | – | |
| -79.5% | -79.5% | -189.1% | -199.1% | -3,147.3% | -5,792.8% | -940.2% | -279.8% | -359.8% | -233.1% | -618.1% | -267.7% | -286.6% | -155.7% | -477.6% | -490.3% | -345.4% | -71.9% | -208.5% | -208.9% | -318.1% | -2,902.8% | -2,245.4% | -17,109.9% | -2,726.7% | -16,239.9% | -49,254.3% | -130,000.0% | |
| -108.1% | -108.1% | -164.9% | -110.5% | -2,787.7% | -7,511.4% | -937.2% | -208.1% | -358.5% | -211.9% | -570.8% | -153.0% | -278.5% | -220.9% | -549.9% | -144.4% | -362.7% | -82.2% | -209.7% | -200.7% | -294.6% | -2,610.6% | -2,018.0% | -16,709.7% | -2,639.8% | -15,671.8% | -47,735.2% | -125,425.9% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.